APOD and myeloid sarcoma: The research conducted by Reindl et al. [134] showed that the ApoD levels in the CSF were significantly higher in chronic inflammatory demyelinating polyneuropathy and Guillain–Barre syndrome (CIDP/GBS) than in MS and non-inflammatory neurological diseases (NNDs).